Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1383-1384, 2003-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sibutramine beneficial in obesity with hyperlipidaemia
Inpharma, Vol. 1, Iss. 1314, 2001-01 ,pp. :
Access to resources
Recommend
Sibutramine and the management of obesity
By Poston Walker S Carlos Foreyt John P
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. :
NICE issues guidance for sibutramine in obesity
Inpharma, Vol. 1, Iss. 1312, 2001-01 ,pp. :
The discovery and status of sibutramine as an anti-obesity drug
European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. :
QOL effects of sibutramine similar to placebo in obesity, diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 450, 2004-01 ,pp. :